Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option
Transl Lung Cancer Res
.
2019 Dec;8(Suppl 4):S378-S382.
doi: 10.21037/tlcr.2019.04.15.
Authors
Biagio Ricciuti
1
,
Giuseppe Lamberti
2
,
Fausto Roila
1
,
Giulio Metro
1
Affiliations
1
Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.
2
Department of Experimental, Diagnostic and Specialty Medicine, Policlinico di Sant'Orsola University Hospital, Bologna, Italy.
PMID:
32038919
PMCID:
PMC6987338
DOI:
10.21037/tlcr.2019.04.15
No abstract available
Publication types
Editorial
Comment